• Recombinant Mouse Macrophage Colony Stimulating Factor (M-CS

  2026-05-26

  Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF) without Tag is a validated macrophage survival and proliferation regulator. It is essential for osteoclast progenitor expansion and macrophage-mediated immune modulation. This dossier details its mechanism, evidence, and protocol optimization, with verifiable citations.

• Crizotinib Hydrochloride in Multi-Lineage Tumor Modelling

  2026-05-26

  Explore how Crizotinib hydrochloride advances ALK kinase inhibitor research within physiologically relevant multi-lineage tumor assembloids. This article delivers nuanced insights for cancer biology research, focusing on tumor–stroma interactions and experimental design.

• Annexin V-APC/7-AAD Apoptosis Kit: Decoding Cell Fate with P

  2026-05-26

  Discover how the Annexin V-APC/7-AAD Apoptosis Kit delivers unparalleled sensitivity for apoptosis detection, with in-depth analysis of its mechanistic advantages and translational value. This article offers a unique perspective, bridging advanced cell death assays with recent breakthroughs in tumor microenvironment research.

• BI 2536: PLK1 Inhibitor Workflows for Cancer Research Excell

  2026-05-25

  BI 2536 is a reference-grade PLK1 inhibitor empowering researchers to dissect cell cycle regulation and apoptosis in cancer models. This guide delivers workflow enhancements, troubleshooting strategies, and practical tips for robust application in both in vitro and in vivo settings.

• BIBR 1532: Precision Telomerase Inhibitor Workflows in Cance

  2026-05-24

  BIBR 1532 offers researchers a highly selective, non-nucleosidic route to telomerase inhibition, enabling advanced studies of cancer cell proliferation and apoptosis. This article delivers stepwise experimental strategies, practical assay enhancements, and troubleshooting guidance for robust telomerase activity and apoptosis readouts, with cross-references to breakthrough telomere-targeting research.

• Bortezomib (PS-341): Applied Proteasome Inhibition Workflows

  2026-05-23

  Unlock deep mechanistic insight using Bortezomib (PS-341), the gold-standard reversible proteasome inhibitor. This guide translates recent research into actionable workflows, troubleshooting, and protocol enhancements for apoptosis, cancer, and neurodegeneration models.

• Veratridine: Voltage-Gated Sodium Channel Opener in Advanced

  2026-05-22

  Veratridine is a benchmark voltage-gated sodium channel opener, enabling reproducible excitotoxicity modeling, seizure mechanism studies, and sodium channel blocker assays. This guide translates current bench research into actionable workflows, troubleshooting strategies, and domain-bridging insights to empower neuroscience and translational teams.

• Lipid Scrambling, Ferroptosis, and Tumor Immunity: Novel Ins

  2026-05-22

  Yang et al. identify TMEM16F-mediated lipid scrambling as a key suppressor of ferroptosis by remodeling plasma membrane phospholipids to mitigate membrane damage. Disrupting this process not only sensitizes tumor cells to ferroptosis, but also enhances anti-tumor immunity, suggesting a new therapeutic angle for cancer treatment.

• Dabigatran’s Impact on Thromboembolic Disorder Management

  2026-05-21

  This review analyzes the clinical evidence for dabigatran, the first oral direct thrombin inhibitor, in the prevention and treatment of thromboembolic disorders. The study highlights its advantages over traditional therapies, such as warfarin, including predictable pharmacokinetics, improved safety, and simplified dosing.

• Acetylcysteine in 3D Co-Culture: Optimizing Oxidative Stress

  2026-05-21

  Harness the dual antioxidant and mucolytic power of Acetylcysteine (N-acetyl-L-cysteine) for advanced 3D organoid-fibroblast co-culture models. This guide details protocol enhancements, troubleshooting, and workflow innovations—backed by the latest research and APExBIO’s high-purity reagent reliability.

• Unraveling Complete Nicotine Biosynthesis: Mechanisms and Ap

  2026-05-20

  Chang et al. (2026) present the first full reconstruction of the nicotine biosynthetic pathway, identifying a vacuolar five-component metabolon and key glycosylation steps crucial for stereoselective coupling. These findings enable precise engineering of nicotine production and provide a framework for dissecting complex alkaloid biosynthesis in both native and heterologous systems.

• Chloroquine (BA1002): Practical Guidance for Research Workfl

  2026-05-20

  Chloroquine (SKU BA1002) is a 4-aminoquinoline compound designed for use as an anti-inflammatory agent for malaria research and as a rheumatoid arthritis research compound. This reagent is best suited for applications involving autophagy inhibition, immune pathway studies, and cell-based assays in cancer and antiviral research. It is not recommended for protocols requiring aqueous solubility or where renal and cardiovascular safety cannot be closely monitored.

• Sulfo-Cy3 NHS Ester: Hydrophilic Fluorescent Dye for Advance

  2026-05-19

  Sulfo-Cy3 NHS ester stands out as a hydrophilic fluorescent dye optimized for robust, water-soluble labeling of proteins and peptides, even those with low solubility. Its unique chemistry reduces quenching and streamlines workflows in cell biology and vascular research, as demonstrated by recent advances in collateral vessel studies.

• ISRIB (trans-isomer): Strategic Insights for Liver Fibrosis

  2026-05-19

  This thought-leadership article explores how ISRIB (trans-isomer), a potent PERK inhibitor, is redefining experimental liver fibrosis research. Blending mechanistic insight with translational strategy, we analyze breakthrough studies on ATF4-driven enhancer programs, outline best-practice protocols, and forecast the evolving landscape for ER stress interventions. APExBIO’s ISRIB (trans-isomer) stands at the intersection of molecular precision and translational opportunity, enabling researchers to probe and therapeutically target the integrated stress response in fibrosis and beyond.

• Ceftolozane Sulfate: Optimized Workflows for Antibacterial R

  2026-05-18

  Ceftolozane sulfate empowers researchers with unmatched potency against multidrug-resistant Pseudomonas aeruginosa, featuring robust stability and reproducibility in both in vitro and in vivo models. This guide details actionable workflows, protocol enhancements, and troubleshooting tips that maximize assay reliability and translational relevance for PK/PD and resistance studies.

454 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page